Squarepoint’s Nuvalent NUVL Stock Holding History

Squarepoint’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15,000	Closed	-$1.53M	–	5363
2024 Q3	$1.53M	Buy	+15,000	New	+$1.24M	﹤0.01%	2268

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Squarepoint's NUVL Position: Q1 2026 in Review

Squarepoint increased its Nuvalent (NUVL) stake by 70% in Q1 2026, buying an estimated $4.39M and bringing the position to 104,801 shares worth $10.7M. The position accounts for 0.01% of the portfolio, ranked #1029.

Squarepoint first reported a position in NUVL in Q4 2022 and has held it in 13 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

Squarepoint held 104,801 shares of Nuvalent worth $10.7M as of Q1 2026.
Squarepoint bought 43,055 Nuvalent shares in Q1 2026, an estimated $4.39M.
Nuvalent made up 0.01% of Squarepoint's portfolio in Q1 2026, its #1029 holding.
Squarepoint first reported a position in Nuvalent in Q4 2022 and has held it in 13 quarters since.
263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.